Frances emailed me and explained that she had a limited remit and space.
Just a reminder that Ian Sample is the head science editor at the Guardian.
His bioscience PhD is from QMUL. Even in the case of ME this may have nothing to do with anything but then again . . .
It's about cognitive biases...
Frances emailed me and explained that she had a limited remit and space. I think she did a good job within that. I think she has her own limits. I do wish Monbiot would bite the bait on this.
Re George Monbiot, for any who might not have already come across it, this piece from 2003 is an illuminating read:
https://www.theguardian.com/education/2003/dec/09/highereducation.uk2
Invasion of the entryists
How did a cultish political network become the public face of the scientific establishment?
George Monbiot, December 9, 2003
Re George Monbiot, for any who might not have already come across it, this piece from 2003 is an illuminating read:
https://www.theguardian.com/education/2003/dec/09/highereducation.uk2
Invasion of the entryists
How did a cultish political network become the public face of the scientific establishment?
George Monbiot, December 9, 2003
That does not mean that the patterns we find are always random chance. I find it extremely unlikely for instance that the SMC are not willingly subject to external influence."Is all this a coincidence?" - actually, it might be? Never underestimate the human power of a good conspiracy. We are pattern seekers by default.
Mark Porter is a GP who does a regular BBC radio program - praising his misinformation is not the way to go if we want to educate him and the public.
The screenshot now shown does not strongly support the case. What is more interesting is the potential reason for failing to show a similar screen shot of the Anton Mayer tweet, which was more severely edited. In these circumstances one would have expected the full screen shots of both to be displayed side-by-side. Why the modesty? Does the full Mayer tweet further undermine the case that has been made.
Thanks info. I agree these sorts of activity diaries and so on are incredibly tedious to plan and keep.Yes. It was a complicated program. The homework was keeping several kinds of diaries, planning activities and so on. https://me-pedia.org/images/8/86/Apt-participant-manual.pdf
Ironicall, I think one of the first things I would drop from my life was such a complicated program because it's not essential.
I don't have sight of the phase III rituximab trial data, but I thought what was remarkable about the early work was that when patient reported improvement occurred, it had a distinct pattern to it, that, to me, suggested something more than a simple placebo effect was going on in a subgroup of patients. In that the improvement wasn't immediately associated with the dose of 'medicine', it followed a delayed repsonse curve correlating with b-cell depleation, and was actually completely unexpected in the early cases where the treatment was for cancer, not ME/CFS.What happened with the rituximab trial was pretty similar to what happened with the anti-viral trials.